肝功能损害患者的替代治疗方法？ - Suppr | 超能文献

An alternative therapy for patients with hepatic impairment?

作者信息

Choo Su-Pin, Venook Alan P

出版信息

Onkologie. 2007 Oct;30(10):474-5. doi: 10.1159/000105958. Epub 2007 Sep 21.

DOI:10.1159/000105958

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

An alternative therapy for patients with hepatic impairment?肝功能损害患者的替代治疗方法？

Onkologie. 2007 Oct;30(10):474-5. doi: 10.1159/000105958. Epub 2007 Sep 21.

2

Effective second-line treatment with cetuximab and bevacizumab in a patient with hepatic metastases of colorectal cancer and hyperbilirubinemia.西妥昔单抗和贝伐单抗对一名患有结直肠癌肝转移和高胆红素血症患者的有效二线治疗。

Onkologie. 2007 Oct;30(10):509-12. doi: 10.1159/000106098. Epub 2007 Sep 21.

3

[Systemic therapy for colorectal cancer].[结直肠癌的全身治疗]

Chirurg. 2005 Jun;76(6):570-2, 574. doi: 10.1007/s00104-005-1038-6.

4

Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver.转移性结直肠腺癌肝转移患者术前全身治疗相关的肝毒性。

Oncologist. 2009 Nov;14(11):1095-105. doi: 10.1634/theoncologist.2009-0152. Epub 2009 Oct 30.

5

Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.在德国环境下，针对 K-ras 野生型结直肠癌患者肝内初始不可切除转移的靶向治疗药物西妥昔单抗的成本效益分析。

Clin Ther. 2011 Apr;33(4):482-97. doi: 10.1016/j.clinthera.2011.04.010.

6

Aneurysm formation in an angiomyolipoma during bevacizumab combination therapy.贝伐单抗联合治疗期间血管平滑肌脂肪瘤中动脉瘤的形成。

Acta Oncol. 2010 Aug;49(6):864-6. doi: 10.3109/02841861003649257.

7

Consequences of chemotherapy on resection of colorectal liver metastases.化疗对结直肠肝转移切除术的影响。

J Visc Surg. 2010 Aug;147(4):e193-201. doi: 10.1016/j.jviscsurg.2010.06.004. Epub 2010 Jul 23.

8

Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancer.贝伐珠单抗联合西妥昔单抗和伊立替康治疗转移性结直肠癌患者在西妥昔单抗和伊立替康治疗失败后的应用。

Acta Oncol. 2011 May;50(4):574-7. doi: 10.3109/0284186X.2010.546369.

9

Skin rash secondary to bevacizumab in a patient with advanced colorectal cancer and relation to response.一名晚期结直肠癌患者使用贝伐单抗后出现的皮疹及其与疗效的关系

Anticancer Drugs. 2006 Nov;17(10):1227-9. doi: 10.1097/01.cad.0000231481.07654.fc.

10

Cetuximab and chemotherapy for patients with unresectable CRC liver metastasis: are we changing the natural course of the disease?西妥昔单抗与化疗用于不可切除的结直肠癌肝转移患者：我们是否正在改变疾病的自然进程？

Onkologie. 2007 Dec;30(12):602-4. doi: 10.1159/000110799. Epub 2007 Nov 30.